Evidence map›Paper›PMID 34956477›Full record

ArticleAmerican journal of translational research2021

Injectable antimicrobial hydrogels with antimicrobial peptide and sanguinarine controlled release ability for preventing bacterial infections.

Jing-Yao Liang, Qian Li, Long-Bao Feng, Sheng-Xue Hu, San-Quan Zhang, Chang-Xing Li, Xi-Bao Zhang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jing-Yao LiangInstitute of Dermatology, Guangzhou Medical University Guangzhou 510095, Guangdong, China.
Qian LiInstitute of Dermatology, Guangzhou Medical University Guangzhou 510095, Guangdong, China.
Long-Bao FengBeogene Biotech (Guangzhou) Co., LTD Guangzhou 510663, Guangdong, China.
Sheng-Xue HuBeogene Biotech (Guangzhou) Co., LTD Guangzhou 510663, Guangdong, China.
San-Quan ZhangInstitute of Dermatology, Guangzhou Medical University Guangzhou 510095, Guangdong, China.
Chang-Xing LiDepartment of Dermatology, Nanfang Hospital, Southern Medical University Guangzhou 510515, Guangdong, China.
Xi-Bao ZhangInstitute of Dermatology, Guangzhou Medical University Guangzhou 510095, Guangdong, China.
Guangzhou Institute of Dermatology · CNBurning Rock Biotech (China) · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic resistant bacteria represents a significant and common clinical problem worldwide as infections are becoming increasingly common. It is urgent to broaden the sources of biomaterials that can prevent both bacterial infection and antibiotic resistance. In this work, oxidized sodium alginate/aminated hyaluronic acid (OSA/AHA) hydrogel with various proportions was developed based on Schiff base reaction. Herein, polydopamine (PDA)-Bmkn2 nanoparticle and sanguinarine were incorporated into hydrogels to enhance antibacterial properties. The prepared PDA-Bmkn2 nanoparticles, with uniform particle size and good dispersion, could serve as a delivery system for Bmkn2. The prepared hydrogels showed appropriate swelling ratio, extremely good mechanical strengths and improved biodegradability. Meanwhile, the Bmkn2 and sanguinarine were released from the hydrogels in a sustainable manner. Furthermore, OSA/AHA/sanguinarine/PDA-Bmkn2 hydrogel (less than 10 μg/mL BmKn2 and 0.2 μg/mL sanguinarine) had excellent biocompatibility. Antibacterial experiments confirmed that OSA/AHA/sanguinarine/PDA-Bmkn2 hydrogel had effective antimicrobial activity on

Indexed as

bacterial infectionsBmkn2HydrogelsPDA nanoparticlesanguinarine

Identifiers

PMID34956477
PMCPMC8661223
OpenAlexW4206880876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.